Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Kymera Therapeutics Inc (NASDAQ: KYMR) closed at $43.51 down -1.23% from its previous closing price of $44.05. In other words, the price has decreased by -$1.23 from its previous closing price. On the day, 0.51 million shares were traded. KYMR stock price reached its highest trading level at $44.805 during the session, while it also had its lowest trading level at $42.87.
Ratios:
For a deeper understanding of Kymera Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.55 and its Current Ratio is at 8.55. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on November 18, 2024, initiated with a Overweight rating and assigned the stock a target price of $65.
Wolfe Research Upgraded its Peer Perform to Outperform on August 26, 2024, while the target price for the stock was maintained at $65.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 17 ’24 when Esposito Pamela sold 13,500 shares for $48.28 per share. The transaction valued at 651,766 led to the insider holds 0 shares of the business.
PAMELA ESPOSITO bought 13,500 shares of KYMR for $654,480 on Sep 17 ’24. On Aug 26 ’24, another insider, Albers Jeffrey W., who serves as the Director of the company, sold 5,000 shares for $49.10 each. As a result, the insider received 245,508 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KYMR now has a Market Capitalization of 2817938176 and an Enterprise Value of 2356198144. For the stock, the TTM Price-to-Sale (P/S) ratio is 32.18 while its Price-to-Book (P/B) ratio in mrq is 3.16. Its current Enterprise Value per Revenue stands at 26.909 whereas that against EBITDA is -12.369.
Stock Price History:
Over the past 52 weeks, KYMR has reached a high of $53.27, while it has fallen to a 52-week low of $18.89. The 50-Day Moving Average of the stock is -7.38%, while the 200-Day Moving Average is calculated to be 6.39%.
Shares Statistics:
For the past three months, KYMR has traded an average of 412.12K shares per day and 412990 over the past ten days. A total of 55.59M shares are outstanding, with a floating share count of 54.85M. Insiders hold about 15.30% of the company’s shares, while institutions hold 93.73% stake in the company. Shares short for KYMR as of 1730332800 were 9161272 with a Short Ratio of 22.23, compared to 1727654400 on 8807131. Therefore, it implies a Short% of Shares Outstanding of 9161272 and a Short% of Float of 15.790000000000001.
